NMR spectroscopic evidence and molecular dynamics studies on inclusion and non-inclusion phenomena between beta-cyclodextrin and new anti-Alzheimer's drugs tacrine (CI-970), velnacrine (HP-029) and suronacrine (HP-128)

被引:19
作者
Amato, ME
Lipkowitz, KB
Lombardo, GM
Pappalardo, GC
机构
[1] INDIANA UNIV PURDUE UNIV,DEPT CHEM,INDIANAPOLIS,IN 46202
[2] UNIV CATANIA,FAC FARM,DIPARTIMENTO SCI CHIM,CATTEDRA CHIM GEN 2,I-95125 CATANIA,ITALY
来源
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 | 1996年 / 03期
关键词
D O I
10.1039/p29960000321
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The formation of supramolecular complexes of beta-CD with new generation anti-Alzheimer's agents of the 1,2,3,4-tetrahydro-9-aminoacridine family (tacrine hydrochloride, 1, velnacrine maleate, 2 and suronacrine maleate, 3), has been studied using molecular dynamics (MD) simulations both in vacuo and with a water sphere, High-field NMR experiments for 1 and 2 gave experimental evidence of their effective non-inclusion. However, earlier NMR studies demonstrated inclusion of 3 on the basis of the observed upheld shifts of the 3-H and 5-H protons of the beta-CD cavity, MD calculations performed for molecules in vacuo gave uncertain results that evidenced failure of this model to reproduce consistently the set of the three experiments, such a failure was overcome by including explicitly water molecules in the model, thus showing that an oversimplified model for modelling complexes of charged molecules is susceptible to incorrect conclusions. The calculations performed for cations 1, 2 and 3 in the water sphere alsb showed that 1 and 2 are more hydrophilic than 3, This suggests that the relative strength of the solvation and of the complex formation constants favours complexation of 3 instead of its non-inclusion, and vice versa in the cases of 1 and 2. An important general aspect of beta-CD supramolecular complexes of charged species was found to be controlled by the solvation effects that must be necessarily included to correctly model, in the absence of safe experimental information like that coming from NMR, inclusion or non-inclusion of a guest into the host.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 15 条
[1]   HIGH-FIELD NMR TECHNIQUES AND MOLECULAR MODELING IN THE STUDY OF THE INCLUSION COMPLEX OF THE COGNITION ACTIVATOR SURONACRINE (HP-128) WITH CYCLODEXTRINS [J].
AMATO, ME ;
PAPPALARDO, GC ;
PERLY, B .
MAGNETIC RESONANCE IN CHEMISTRY, 1993, 31 (05) :455-460
[2]   SOLID-STATE STRUCTURES AND CONFORMATIONAL STUDIES OF 4 1,2,3,4-TETRAHYDROACRIDINE ALZHEIMERS-DISEASE THERAPEUTICS [J].
BANDOLI, G ;
DOLMELLA, A ;
GATTO, S ;
NICOLINI, M .
JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, 1994, 24 (05) :301-310
[3]  
Bergeron R. J., 1984, INCLUSION COMPOUNDS, V3, P391
[4]   ATOMIC CHARGES DERIVED FROM SEMIEMPIRICAL METHODS [J].
BESLER, BH ;
MERZ, KM ;
KOLLMAN, PA .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :431-439
[5]  
BRESLOW R, 1984, INCLUSION COMPOUNDS, V3, P473
[6]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[7]  
Duchene D., 1991, NEW TRENDS CYCLODEXT
[9]  
Job P, 1928, ANN CHIM FRANCE, V9, P113
[10]   9-AMINO-1,2,3,4-TETRAHYDROACRIDIN-1-OLS - SYNTHESIS AND EVALUATION AS POTENTIAL ALZHEIMERS-DISEASE THERAPEUTICS [J].
SHUTSKE, GM ;
PIERRAT, FA ;
KAPPLES, KJ ;
CORNFELDT, ML ;
SZEWCZAK, MR ;
HUGER, FP ;
BORES, GM ;
HAROUTUNIAN, V ;
DAVIS, KL .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) :1805-1813